Loading
institutionsInstitution
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago's Northwestern cancer centre, a world leader in brain tumour therapy from Tumour Treating Fields to ultrasound opening of the blood-brain barrier.
Also called: Lurie Cancer Center
Overview
NCI-designated since 1993 and comprehensive since 1997, the Lurie Cancer Center is anchored at Northwestern Memorial Hospital on Chicago's Streeterville campus. Roger Stupp, who defined the temozolomide chemoradiation standard for glioblastoma, led the EF-14 trial that brought Tumour Treating Fields (Optune) into first-line glioblastoma care; Adam Sonabend's team has shown that implantable ultrasound can open the blood-brain barrier to deliver chemotherapy and antibodies. Other strengths include breast oncology (William Gradishar), haematologic malignancies, prostate cancer and cancer survivorship research. The centre serves the Chicago metropolitan area through Northwestern Medicine's regional network.
Location
Chicago, IL, US
Type
cancer center · Northwestern University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#79 · 43 points (0 Newsweek + 15 NCI + 28 from 14 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Robert H. Lurie Comprehensive Cancer Center of Northwestern University, including child institutions. 264 works · 7,039 citations · 67% open access · 16% clinical trials · 2% reviews.
Oncology works per year
552022
462023
602024
602025
432026
Most works
- Leo I. Gordon35 works
- Reem Karmali31 works
- Jane N. Winter17 works
- Shuo Ma17 works
- Jonathan Moreira15 works
- Lindsey Fitzgerald15 works
- Narendranath Epperla15 works
- Thomas Ollila14 works
- Geoffrey Shouse14 works
- Vaishalee P. Kenkre14 works
Most cited
- Neuro-oncology (Malnati Brain Tumor Institute)
- Tumour Treating Fields
- Ultrasound blood-brain barrier opening
- Breast oncology
Ann Lurie
Nurse and philanthropist behind Northwestern's Robert H. Lurie Comprehensive Cancer Center
Cancer centre buildingPaediatric hospital building
After her husband Robert was diagnosed with advanced colon cancer in 1987 at 46, she turned the family's fortune to Northwestern's cancer centre, which carries his name, and to the children's hospital that carries both.
Maha Hussain
Genevieve E. Teuton Professor of Medicine and Deputy Director, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Prostate cancerPARP inhibitorsAndrogen deprivation strategies
Led PROSPER and the PROfound survival analysis, and settled the intermittent hormone therapy question with SWOG 9346.
Roger Stupp
Professor of Neurological Surgery and Neurology, Northwestern University; formerly Lausanne and EORTC
Neuro-oncologyGlioblastomaTumour treating fields
Led the EORTC/NCIC trial that made temozolomide with radiotherapy the glioblastoma standard, and the EF-14 trial of tumour treating fields.
Similar pages
- TrialEF-14
Shares Roger Stupp, Novocure, Optune / Optune Pax (TTFields), Tumour treating fields (TTFields).
- TrialSTELLAR
Shares Novocure, Optune / Optune Pax (TTFields), Tumour treating fields (TTFields).
- InstitutionUniversity of Florida Health Cancer Center
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, The brain: barrier and sanctuary, Proton therapy, National Cancer Institute (NIH).
- TrialEF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Shares Novocure, Temozolomide, Glioma & glioblastoma.
- TrialPANOVA-3
Shares Novocure, Optune / Optune Pax (TTFields), Tumour treating fields (TTFields).
- Key paperTumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study
Shares Novocure, Optune / Optune Pax (TTFields), Tumour treating fields (TTFields).
- TrialEORTC 26981 / NCIC CE.3 (Stupp trial)
Shares Roger Stupp, The brain: barrier and sanctuary, Temozolomide, Glioma & glioblastoma.
- Key paperStupp 2005: temozolomide added to radiotherapy for newly diagnosed glioblastoma
Shares Roger Stupp, Tumour treating fields (TTFields), The brain: barrier and sanctuary, Glioma & glioblastoma.
cancers
fronts
technologies
drugs
ApprovedDevice (tumour treating fields)
Optune / Optune Pax (TTFields) · Optune
ApprovedOral alkylating chemotherapy
Temozolomide · Temodar